Public Comment – Clinical Practice Guideline: Improving Nasal Form and Function after Rhinoplasty

Wednesday, June 29 - Wednesday, July 13 

This area of the Portal requires a log in.  

A draft of the Clinical Practice Guideline (CPG): Improving Nasal Form and Function after Rhinoplasty is now available for public comment. The comment period will run from noon ET on Wednesday, June 29 through 11:00 PM ET, Wednesday, July 13, 2016. During this time, members of the public are encouraged to review the guideline and provide comments. While the goal of this phase is to obtain public comment, we also encourage other stakeholders to participate, if they so desire. The purpose of the comment period is to ensure that all stakeholders have an opportunity to review the guideline recommendations, action statement profiles, and supporting text prior to publication.

Please remember that this guideline is intended for any clinician or individual, in any setting, involved in the management of rhinoplasty patients. The target population is all patients age 15 years and older.

We ask non-healthcare professionals, specifically, to pay close attention to the evidence profile of each action statement. Action statement profiles contain information regarding the role of patient preferences, benefit/harm assessment, and intentional vagueness, which may be most relevant to members of the public.

To participate in the public comment, users must agree not to distribute or share the draft guideline with any other individuals or organizations prior to the official publication of the guideline, and must disclose any conflicts of interest. Following conflict of interest disclosure, a PDF of the guideline document will then become available, and users will receive a link to the comment page.

If you have any problems logging in with your username and password, please contact Lorraine Nnacheta at or Phone: 703-535-3751.

If you are a member and know your login Click Here

To retrieve your password Click Here
To create a login account Click Here

If you have any questions or problems please email